Development and evaluation of a decision aid for HPV vaccination among adults aged 27–45 years old in the United States

被引:0
|
作者
Wheldon, Christopher W. [1 ]
Grace, Jessica [2 ,6 ]
Zimet, Gregory [3 ]
Daley, Ellen M. [4 ]
Akpan, Idara N. [2 ]
Alkhatib, Sarah A. [2 ]
Thompson, Erika L. [2 ,5 ]
机构
[1] Department of Social & Behavioral Sciences, College of Public Health, Temple University, 1301 Cecil B. Moore Ave., Philadelphia,PA,19122, United States
[2] Department of Population and Community Health, School of Public Health, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth,TX,76107, United States
[3] Department of Population and Community Health, School of Public Health, Pediatrics, Indiana University School of Medicine and Zimet Research Consulting LLC, 1625 Sturbridge Road, Indianapolis,IN,46260, United States
[4] College of Public Health, University of South Florida, Tampa, FL, 13201 Bruce B. Downs Blvd, MDC 56, Tampa,FL,33612, United States
[5] Department of Quantitative and Qualitative Health Sciences, University of Texas School of Public Health San Antonio, University of Texas Health Science Center at San Antonio, 8403 Floyd Curl Drive, San Antonio,TX,78229, United States
[6] Department of Social Work, College of Health and Public Service, University of North Texas, 410 Ave. C, Denton,TX,76201, United States
关键词
D O I
10.1016/j.compbiomed.2024.109557
中图分类号
学科分类号
摘要
Objective: To design, develop, and field test the HPV Decide decision tool to facilitate shared clinical decision-making recommendation for mid-adult HPV vaccination. Methods: The ‘HPV Decide’ online tool was developed through a 6-step process, involving community and provider advisory boards, usability testing with 10 end users (unvaccinated adults aged 27–45), field testing interviews with another 10, and interviews with 18 healthcare providers. The process incorporated both inductive and deductive qualitative data analyses. Results: The logic model, based on the Ottawa Decision Support Framework, highlighted the importance of objective knowledge and managing decisional conflict. Iterative modifications were informed by the advisory boards, alpha testing, and usability testing. Field testing showed utility to end users, highlighting the straightforward design, and lack of medical jargon. Many expressed a desire to access the tool before doctor appointments, emphasizing its value in a healthcare context and in partnership with providers. Lastly, healthcare provider feedback highlighted information quality, structure, acceptability, and future implementation. Discussion: While users recognized the tool's information quality and user-centric design, full evaluation focused on changes in informed decision making and clinic-based implementation are needed. Practical value: The HPV Decide decision tool demonstrates promise in supporting informed decisions about HPV vaccination among mid-adults. © 2024 Elsevier Ltd
引用
收藏
相关论文
共 50 条
  • [21] Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States
    Chesson, Harrell W.
    Meites, Elissa
    Ekwueme, Donatus U.
    Saraiya, Mona
    Markowitz, Lauri E.
    VACCINE, 2018, 36 (29) : 4362 - 4368
  • [22] Risk of Falls in adults 45-64 years old in the United States
    Amiri, Azita
    Dong, Xiaoxia
    Frith, Karen
    PUBLIC HEALTH NURSING, 2022, 39 (06) : 1235 - 1245
  • [23] Influenza vaccination recommended for all adults aged 50 years and older, United States
    Strikas, RA
    Bridges, CB
    Singleton, JA
    OPTIONS FOR THE CONTROL OF INFLUENZA IV, 2001, 1219 : 665 - 669
  • [24] Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model
    Chesson, Harrell W.
    Meites, Elissa
    Ekwueme, Donatus U.
    Saraiya, Mona
    Markowitz, Lauri E.
    VACCINE, 2020, 38 (50) : 8032 - 8039
  • [25] Pneumococcal and influenza vaccination levels among adults aged >= 65 years - United States, 1993 (Reprinted from MMWR, vol 45, pg 859, 1996)
    Durham, J
    Owen, P
    Bender, B
    Senner, J
    Davis, B
    Leff, M
    Adams, M
    Breukelman, F
    Mitchell, C
    McTague, D
    Pledger, E
    Cooper, J
    Johnson, C
    Steiner, B
    Costello, N
    Busick, P
    Perry, M
    Asher, K
    Meriwether, R
    Maines, D
    Weinstein, A
    Brooks, D
    McGee, H
    Salem, N
    Loyd, S
    JacksonThompson, J
    Smith, P
    Huffman, S
    DeJan, E
    Zaso, K
    Boeselager, G
    Honey, W
    Melnik, T
    Lengerich, G
    Kaske, J
    Indian, R
    Hann, N
    GrantWorley, J
    Mann, L
    Hesser, J
    Ferguson, J
    Gildemaster, M
    Ridings, D
    Diamond, R
    Giles, R
    McIntyre, R
    Stones, J
    WynkoopSimmons, K
    King, F
    Cautley, E
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19): : 1544 - 1545
  • [26] Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years - United States, 2019
    Omura, John D.
    McGuire, Lisa C.
    Patel, Roshni
    Baumgart, Matthew
    Lamb, Raza
    Jeffers, Eva M.
    Olivari, Benjamin S.
    Croft, Janet B.
    Thomas, Craig W.
    Hacker, Karen
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (20): : 680 - 685
  • [27] Human papillomavirus vaccination uptake among 27-to-45-year-olds in the United States
    Akpan, Idara N.
    Taskin, Tanjila
    Wheldon, Christopher W.
    Rossheim, Matthew E.
    Thompson, Erika L.
    PREVENTIVE MEDICINE, 2024, 182
  • [28] Acceptability and Uptake of a Postpartum HPV Vaccination Program Among Women 15-45 Years Old
    Sao, Saumya
    Wang, Runzhi
    Thaker, Sejal
    Gingher, Erin
    Lander, Megan
    Moss, Chailee
    Chou, Betty
    Coleman, Jenell
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : 321 - 322
  • [29] Trends in human papillomavirus vaccination among women aged 27 to 45 years, from 2017 to 2019
    Kulkarni, Amita
    Chen, Ling
    Melamed, Alexander
    Hershman, Dawn L.
    Wright, Jason D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (04) : 568 - 570
  • [30] HUMAN PAPILLOMAVIRUS (HPV) VACCINE UPTAKE AND INTENTIONS AMONG ADULTS AGES 18-45 YEARS LIVING IN THE UNITED STATES
    Christy, Shannon M.
    Brownstein, Naomi
    Whiting, Junmin
    Kasting, Monica L.
    Head, Katharine J.
    Barrios-Monroy, Veronica
    Best, Alicia L.
    Gwede, Clement K.
    Meade, Cathy D.
    Giuliano, Anna
    Vadaparampil, Susan T.
    ANNALS OF BEHAVIORAL MEDICINE, 2022, 56 (SUPP 1) : S370 - S370